Government ❯ Regulation ❯ FDA

Drug Approval

Mifepristone Compounding Pharmacies Patient Safety Safety Communications NDA Clinical Trials Labeling Changes Agricultural Products Animal Health Solutions Sunscreen Ingredients Exdensur Psychedelic Drug Public Health Mifepristone Approval Public Health Safety New Drug Application

FDA Clears GSK’s Exdensur as First Twice-Yearly Add-On for Severe Eosinophilic Asthma

The long-acting IL-5 antibody targets eosinophilic disease with a dosing schedule GSK says could improve adherence.

FDA Proposes Adding Bemotrizinol to U.S. Sunscreens, Invites Public Comment

FDA Grants Conditional Approval to Exzolt Cattle-CA1 for Screwworm and Cattle Fever Tick

FDA Investigates Fatal Liver Failures Linked to Sarepta’s Elevidys Therapy

Democratic-Led States Petition FDA to Remove Mifepristone Restrictions